Intravenous Immunoglobulin Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The global intravenous immunoglobulin market is anticipated to witness an uptick with the development of social society leading to changes in diet and other lifestyles. This along with the rapidly growing aging population across the globe is causing an increase in the number of patients having primary immunodeficiency and other rare immunological disorders. For instance, more than 500,000 persons in the United States suffer from more than 200 distinct types of primary immunodeficiency diseases (PIDs), as per the NIH data. Also, according to the U.S. National Library of Medicine and National Institute of Health, nearly 6 million patients are suffering from PID worldwide. Furthermore, increased investment in the healthcare industry and growing adoption of immunoglobin with product launches and approvals are also some other factors contributing to the growth of the market globally.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22667

According to UnivDatos Market Insights (UMI)’ research report “Global Intravenous Immunoglobulin Market Analysis, 2020”, the intravenous immunoglobulin market is projected to grow at a CAGR of around 7% during 2021-27F. A large number of ongoing research activities in this field, rising government and public-private investments, and various advantages associated with the implementation of intravenous immunoglobulin are some of the prominent factors contributing to the growth of the market globally.

Based on the application, the intravenous immunoglobulin market is divided into hypogammaglobulinemia, CIDP, myasthenia gravis, Guillain-barre syndrome, immunodeficiency diseases, and others. The hypogammaglobulinemia segment occupied the major share of the intravenous immunoglobulin market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years as it is one of the most common primary immunodeficiency which encompasses a majority of immune-compromised patients. However, the CIDP segment is also expected to grow considerably during the upcoming years.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22667  

Hospital Segment to Witness Robust growth

Based on end-users, the market is fragmented into hospitals, clinics, and homecare. In 2020, the hospitals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing number of hospitals and growing adoption of intravenous immunoglobulin products in hospitals. Also, the presence of well-trained healthcare professionals, well-established infrastructure, and ease of time-to-time monitoring of patients in hospitals are some of the factors contributing to the growth of this segment. However, clinics are also likely to witness lucrative growth during the forecast period.

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global intravenous immunoglobulin market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established market players and frequent product launches in the region. North America is expected to skyrocket with a considerable CAGR during the forecast period, as stated in UnivDatos Market Insights (UMI)’ research report “Global Intravenous Immunoglobulin Market Analysis, 2020”. 

For more informative information, please visit us – https://univdatos.com/report/intravenous-immunoglobulin-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Intravenous immunoglobulin Market include Biotest AG, Baxter International Inc., Octapharma AG, China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., Pfizer Inc., LFB Biomedicaments S.A., Baxalta, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Intravenous Immunoglobulin Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for intravenous immunoglobulin providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/intravenous-immunoglobulin-market/

Market Segmentation:

1.     By Product (IgG, IgE, IgA, IgD, and IgM)

2.     By Application (Hypogammaglobulinemia, Cidp, Myasthenia Gravis, Guillain-Barre Syndrome, Immunodeficiency Diseases, and Others)

3.     By End-Users (Hospitals, Clinics, and Homecare)

4.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.     By Company (Biotest AG, Baxter International Inc., Octapharma AG, China Biologic Products, Inc., CSL Behring LLC, Grifols S.A., Kedrion S.p.A., Pfizer Inc., LFB Biomedicaments S.A., Baxalta, etc.)

Key questions answered in the study:

1.     What are the current and future trends of the intravenous immunoglobulin industry?

2.     How the industry has been evolving in terms of product, application, and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the intravenous immunoglobulin industry?

5.     What is the customer orientation, purchase behavior, and expectations from intravenous immunoglobulin firms across various regions? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET COVID-19 IMPACT

6 GLOBAL INTRAVENOUS IMMUNOGLOBULIN MARKET REVENUE 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY END-USERS

10 MARKET INSIGHTS BY REGION

11 INTRAVENOUS IMMUNOGLOBULIN MARKET DYNAMICS

12 INTRAVENOUS IMMUNOGLOBULIN MARKET OPPORTUNITIES

13 INTRAVENOUS IMMUNOGLOBULIN MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       3D Bioprinting of Living Human Tissues/Organs Market is growing by leaps and bounds with Top Key players like 3Dynamic Systems, Aspect Biosystems, Allevi, BioDan

·       Lack of Donors Driving the Wearable Artificial Organs Market: Current Analysis and Forecast with Different Segments, Key Players Insights

·       Mobile Health Application (mHealth Apps) Market to Reach US$ 315.4 Billion by 2027, Globally |CAGR: 44.4%

·       Nanotechnology in Drug Delivery Market to Reach US$ 182.3 Billion by 2027, Globally | CAGR: 19.9% |